MicroRNA-21 as a potential colon and rectal cancer biomarker

doi:10.3748/wjg.v19.i34.5615

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 34

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6826)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

446

HTML

4533

Figures (1-1)

266

Tables (1-2)

249

Sum=5494

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

727

Download

605

Sum=1332

Sep 14, 2013 (publication date) through Feb 3, 2025

Times Cited of This Article

Times Cited (58)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Sep 14, 2013; 19(34): 5615-5621
Published online Sep 14, 2013. doi: 10.3748/wjg.v19.i34.5615

Table 1 Current screening methods and guidelines for colorectal cancer

Method	Sensitivity	Interval	Society
Fecal tests
FOBT		Yearly	USPSTF, ASGE,
			USMSTF
FIT	65.8%[32,33]	Yearly
Fecal DNA	50%-60%[34]	Unspecified	USMSTF
Serum markers
CEA	30%[35]
CA19-9
Imaging tests
DCBE	85%-97%[36]	Every 5 years	USMSTF
CTC	55%-94%[37]	Every 5 years	USMSTF
Optical tests
FS		Every 5 years	USPSTF, ASGE, USMSTF
		Every 10 years
FC			USPSTF, ASGE, USMSTF

FOBT: Fecal occult blood test; FIT: Fecal immunochemical based stool tests; CEA: Carcinoembryonic antigen; DCBE: Double-contrast barium enema; CTC: Computed tomography colonography; FS: Flexible sigmoidoscopy; FC: Flexible colonoscopy; USPSTF: United States Preventive Services Task Force; ASGE: American Society for Gastrointestinal Endoscopy; USMSTF: Multi-Society Task Force on Colorectal Cancer.

Citation: Li T, Leong MH, Harms B, Kennedy G, Chen L. MicroRNA-21 as a potential colon and rectal cancer biomarker. World J Gastroenterol 2013; 19(34): 5615-5621
URL: https://www.wjgnet.com/1007-9327/full/v19/i34/5615.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i34.5615